Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to 0.1%.

  • Utah Medical Products' Return on Capital Employed fell 200.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.02% for FY2024, which is 0.0% changed from last year.
  • Per Utah Medical Products' latest filing, its Return on Capital Employed stood at 0.1% for Q3 2025, which was down 200.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Return on Capital Employed ranged from a high of 0.18% in Q3 2022 and a low of 0.1% during Q3 2025
  • Moreover, its 5-year median value for Return on Capital Employed was 0.14% (2023), whereas its average is 0.14%.
  • Per our database at Business Quant, Utah Medical Products' Return on Capital Employed plummeted by -400bps in 2021 and then skyrocketed by 500bps in 2022.
  • Utah Medical Products' Return on Capital Employed (Quarter) stood at 0.17% in 2021, then rose by 4bps to 0.17% in 2022, then dropped by -24bps to 0.13% in 2023, then dropped by -15bps to 0.11% in 2024, then dropped by -10bps to 0.1% in 2025.
  • Its Return on Capital Employed was 0.1% in Q3 2025, compared to 0.11% in Q2 2025 and 0.11% in Q1 2025.